×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Sleeping Bruxism Treatment Market

ID: MRFR/HC/12191-HCR
200 Pages
Rahul Gotadki
October 2025

US Sleeping Bruxism Treatment Market Research Report By Type (Primary Bruxism, Secondary Bruxism), By Treatment (Dental Approaches, Medication), By Cause (Obstructive Sleep Apnea, Gastroesophageal Reflux Disease, Malocclusion, Sleep Paralysis), By Patient Type (Pediatric, Adult) and By End User (Hospitals & Clinics, Dental Clinics) - Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Sleeping Bruxism Treatment Market Infographic
Purchase Options

US Sleeping Bruxism Treatment Market Summary

As per MRFR analysis, the US sleeping bruxism-treatment market size was estimated at 129.5 USD Million in 2024. The US sleeping bruxism-treatment market is projected to grow from 137.89 USD Million in 2025 to 258.39 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 6.48% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The US sleeping bruxism-treatment market is experiencing growth driven by increased awareness and technological advancements.

  • The market is witnessing a rise in awareness and diagnosis of sleeping bruxism. This trend is leading to more individuals seeking treatment.
  • Technological advancements in dental devices are enhancing treatment options for bruxism, making them more effective and accessible.
  • Holistic treatment approaches are gaining traction, reflecting a shift towards comprehensive care in managing bruxism.
  • the rising incidence of sleep disorders and increased focus on oral health are key drivers of market growth.

Market Size & Forecast

2024 Market Size 129.5 (USD Million)
2035 Market Size 258.39 (USD Million)
CAGR (2025 - 2035) 6.48%

Major Players

Procter & Gamble (US), GlaxoSmithKline (GB), Johnson & Johnson (US), Colgate-Palmolive (US), Dentsply Sirona (US), 3M (US), Kavo Kerr (US), Oral-B (US)

US Sleeping Bruxism Treatment Market Trends

The sleeping bruxism-treatment market is currently experiencing notable developments, driven by a growing awareness of the condition and its potential health implications. Bruxism, characterized by the involuntary grinding or clenching of teeth during sleep, can lead to various complications, including dental damage, jaw pain, and sleep disturbances. As more individuals recognize the adverse effects of this condition, there is an increasing demand for effective treatment options. This trend is further supported by advancements in dental technology and the introduction of innovative therapeutic solutions, which appear to enhance patient outcomes and satisfaction. Moreover, the rising prevalence of stress and anxiety in the population seems to correlate with the incidence of bruxism, prompting healthcare providers to focus on comprehensive treatment approaches. These approaches often encompass behavioral therapies, dental devices, and lifestyle modifications, indicating a shift towards holistic management strategies. As the sleeping bruxism-treatment market evolves, it is likely to witness further growth, driven by ongoing research and development efforts aimed at improving treatment efficacy and accessibility. The integration of telehealth services may play a role in expanding patient reach and facilitating timely interventions. This could enhance overall market dynamics.

Increased Awareness and Diagnosis

There is a growing recognition of bruxism as a significant health issue, leading to more individuals seeking diagnosis and treatment. This trend is likely fueled by educational campaigns and healthcare provider initiatives aimed at informing the public about the condition's risks.

Technological Advancements in Treatment

Innovations in dental technology are transforming the sleeping bruxism-treatment market. New devices and therapeutic options are emerging, offering improved comfort and effectiveness for patients, which may enhance adherence to treatment.

Holistic Treatment Approaches

The market is witnessing a shift towards comprehensive treatment strategies that address both the physical and psychological aspects of bruxism. This trend suggests a growing emphasis on integrating behavioral therapies alongside traditional dental interventions.

US Sleeping Bruxism Treatment Market Drivers

Increased Focus on Oral Health

The growing emphasis on oral health in the US is significantly impacting the sleeping bruxism-treatment market. With rising awareness about the consequences of untreated bruxism, including dental wear and temporomandibular joint disorders, more individuals are seeking preventive and corrective treatments. The American Dental Association has reported that nearly 10% of adults suffer from bruxism, prompting dental professionals to advocate for early intervention. This focus on oral health is likely to drive the demand for custom dental appliances and other therapeutic options. Additionally, as dental insurance plans increasingly cover bruxism treatments, more patients may pursue these solutions, further propelling market growth. The sleeping bruxism-treatment market is thus positioned to benefit from this heightened awareness and proactive approach to oral health.

Advancements in Dental Technology

Technological innovations in dental care are transforming the sleeping bruxism-treatment market. The introduction of advanced diagnostic tools, such as digital imaging and sleep monitoring devices, allows for more accurate assessments of bruxism severity. Moreover, the development of custom-fitted dental guards using 3D printing technology enhances patient comfort and compliance. These advancements not only improve treatment outcomes but also encourage more patients to seek help for their bruxism issues. The market is expected to grow as these technologies become more accessible and affordable. Furthermore, the integration of telehealth services in dental care provides patients with convenient access to consultations and follow-ups, potentially increasing treatment adherence. Overall, these technological advancements are likely to play a crucial role in shaping the future of the sleeping bruxism-treatment market.

Rising Incidence of Sleep Disorders

The increasing prevalence of sleep disorders in the US is a notable driver for the sleeping bruxism-treatment market. Studies indicate that approximately 30% of adults experience sleep disturbances, which can exacerbate bruxism. As awareness of the connection between sleep quality and bruxism grows, more individuals seek treatment options. This trend is likely to boost demand for various therapeutic solutions, including dental devices and behavioral therapies. The market is projected to expand as healthcare providers recognize the need for effective interventions. Furthermore, the rising incidence of stress-related disorders, which often contribute to bruxism, adds to the urgency for effective treatment options. Consequently, the sleeping bruxism-treatment market is expected to witness significant growth as more patients are diagnosed and treated for sleep-related issues.

Expansion of Dental Insurance Coverage

The expansion of dental insurance coverage for bruxism treatments is a significant driver for the sleeping bruxism-treatment market. As insurance providers increasingly recognize bruxism as a legitimate dental concern, more patients are likely to seek treatment options. This trend is particularly relevant in the context of rising healthcare costs, where patients are more inclined to pursue covered treatments. The availability of financial support for dental appliances and therapeutic interventions can lead to higher treatment rates among affected individuals. Additionally, as more employers offer comprehensive dental plans that include bruxism treatments, the market is expected to grow. This shift in insurance coverage is likely to enhance accessibility to necessary treatments, thereby positively impacting the sleeping bruxism-treatment market.

Growing Awareness of Stress Management

The rising recognition of stress management as a critical component of overall health is influencing the sleeping bruxism-treatment market. Stress is a well-documented trigger for bruxism, and as more individuals acknowledge its impact on their well-being, there is a corresponding increase in demand for stress-reduction therapies. Techniques such as mindfulness, cognitive behavioral therapy, and relaxation exercises are gaining popularity, leading to a holistic approach to bruxism treatment. This trend may encourage healthcare providers to incorporate stress management strategies into their treatment plans, thereby expanding the range of options available to patients. As awareness of the link between stress and bruxism continues to grow, the sleeping bruxism-treatment market is likely to experience a shift towards more comprehensive treatment modalities.

Market Segment Insights

By Type: Primary Bruxism (Largest) vs. Secondary Bruxism (Fastest-Growing)

In the US sleeping bruxism-treatment market, Primary Bruxism holds the largest share, dominating the market landscape due to its more common occurrence among individuals. This segment accounts for a significant portion of treatment demand, as many patients seek solutions for the persistent grinding of teeth primarily associated with stress, anxiety, or misaligned teeth. On the other hand, Secondary Bruxism is gaining traction, attributed to underlying health conditions and medications that increase muscle activity, leading to a rapid rise in diagnosed cases compared to its counterpart. Growth trends for these segments indicate that while Primary Bruxism remains the stable foundation of the market, Secondary Bruxism is emerging as a fast-growing area driven by increasing awareness of health issues leading to this condition. As healthcare professionals become more adept at identifying and treating Secondary Bruxism, the willingness of patients to pursue treatment options is fostering a swift expansion. This dynamic is contributing to a more diverse treatment portfolio and presenting new opportunities for market players.

Primary Bruxism (Dominant) vs. Secondary Bruxism (Emerging)

Primary Bruxism is characterized by its prevalence, being the primary focus of treatment strategies within the US sleeping bruxism-treatment market. Typically associated with stress and anxiety, this segment benefits from well-established treatment modalities including custom dental guards and behavioral therapy options designed to alleviate symptoms. In contrast, Secondary Bruxism represents an emerging segment, increasingly recognized for its link to other health issues such as sleep apnea and certain medications. As awareness grows, this segment is seeing innovative treatment solutions being developed, making it a vital area for growth. The differentiation in treatment approaches between these two segments underscores the market's adaptability and potential for expansion driven by evolving patient needs.

By Cause: Obstructive Sleep Apnea (Largest) vs. Gastroesophageal Reflux Disease (GERD) (Fastest-Growing)

In the US sleeping bruxism-treatment market, the predominant causes include Obstructive Sleep Apnea (OSA), Gastroesophageal Reflux Disease (GERD), Malocclusion, and Sleep Paralysis. Among these, OSA holds the largest market share due to its high prevalence and the strong correlation with sleep bruxism. GERD emerges as a leading cause as well, especially given its rising awareness and growing incidences, marking it as a significant contributor to bruxism-related issues in patients. Growth trends in the segment indicate a robust increase in the diagnosis and treatment of OSA, driven by heightened awareness and advances in medical technology. Conversely, GERD is on a rapid growth trajectory as healthcare providers increasingly recognize its impact on sleep disorders. The interplay between these conditions and factors such as lifestyle changes, diet, and stress management are pivotal drivers for market dynamics within this segment.

Obstructive Sleep Apnea (Dominant) vs. Gastroesophageal Reflux Disease (GERD) (Emerging)

Obstructive Sleep Apnea (OSA) is a critical factor in the US sleeping bruxism-treatment market, recognized for its dominant influence due to its high occurrence in sleep clinics. Patients with OSA often experience significant disruptions in sleep, leading to increased incidence of bruxism as a physical response to stress on the body during sleep. In contrast, Gastroesophageal Reflux Disease (GERD) is emerging as a prominent segment as more research uncovers the links between acid reflux and sleep disturbances, including bruxism. This evolving understanding highlights GERD's role as an impactful emerging cause, further emphasized by a societal shift towards addressing gastrointestinal health in connection with overall wellness and sleep quality.

By Treatment: Mouth Guard (Largest) vs. NTI-TSS Device (Fastest-Growing)

In the US sleeping bruxism-treatment market, the distribution of market share among the various treatment options reveals that Mouth Guards hold the largest segment, being widely favored due to their simplistic design and effectiveness in preventing tooth wear. Other treatments such as the NTI-TSS Device and Medication categories also show significant shares, but they do not surpass the dominance of Mouth Guards, which have become the go-to option for managing bruxism effectively. Recently, the market has been witnessing growth trends driven by increasing awareness of dental health and the adverse effects of bruxism. The NTI-TSS Device, in particular, has gained traction and is recognized as the fastest-growing segment due to its clinical efficacy and user-friendliness. Additionally, growing interest in alternative therapies like botulinum toxin type A injections showcases evolving consumer preferences towards innovative solutions for treatment.

Mouth Guard: Dominant vs. NTI-TSS Device: Emerging

Mouth Guards remain the dominant treatment option in the US sleeping bruxism-treatment market, known for their customizability and comfort, significantly aiding in the prevention of dental damage caused by bruxism. They are frequently recommended by dental professionals and popular among users due to their accessibility and proven effectiveness. In contrast, the NTI-TSS Device is an emerging option with strong growth, primarily targeting specific muscle relaxation during sleep. Its unique design helps minimize clenching forces, making it a favored choice among patients looking for alternative methods. The rise of NTI-TSS is indicative of a broader trend towards innovative dental solutions, making the competition between traditional and novel treatments increasingly dynamic.

By Patient Type: Adult (Largest) vs. Pediatric (Fastest-Growing)

In the US sleeping bruxism-treatment market, Adults represent the largest segment, capturing a significant share due to higher prevalence rates among this demographic. Pediatric cases, although fewer, are increasingly recognized, leading to a growing market share as awareness about this condition in children rises. The balanced distribution of male and female patients within these categories further highlights the diverse target audience for treatment options. Growth trends indicate a rising demand for tailored solutions targeting both Adult and Pediatric patients. Factors driving this growth include increasing stress levels leading to bruxism, along with heightened awareness and diagnosis rates in clinical settings. Moreover, innovative treatment solutions and preventive measures are giving parents and adults more options, consequently fueling market expansion in both segments.

Adult (Dominant) vs. Pediatric (Emerging)

The Adult segment is characterized by a higher occurrence of bruxism, driven by lifestyle factors such as stress and anxiety, making it the dominant patient type within the market. Treatments are often focused on custom dental solutions and stress management techniques. Conversely, the Pediatric segment, although smaller, represents an emerging space due to increased awareness and a growing understanding of bruxism in children. Parents are becoming more proactive in seeking treatment for their children, prompting manufacturers to develop specialized pediatric devices. As a result, while Adults maintain market dominance, the Pediatric segment is expected to witness significant growth in the coming years.

By End User: Dental Clinics (Largest) vs. Hospitals & Clinics (Fastest-Growing)

In the US sleeping bruxism-treatment market, the distribution of market share reveals that dental clinics hold a substantial share. They are preferred by many patients due to specialized services and tailored treatments that focus on dental health. Meanwhile, hospitals and clinics, while important, have a smaller share in comparison, as patients often seek dental clinics specifically for bruxism-related issues, leading to a clear dominance in market preference. However, hospitals and clinics are witnessing rapid growth in this segment driven by an increasing awareness of sleep disorders and the need for comprehensive treatment approaches. As healthcare providers expand their services to include dental care for bruxism, this sector is becoming the fastest-growing. Enhanced collaboration between dental professionals and hospitals is also contributing to this uptrend, addressing a broader patient demographic.

Dental Clinics (Dominant) vs. Hospitals & Clinics (Emerging)

Dental clinics are the dominant players in the US sleeping bruxism-treatment market due to their specialized focus on dental health and bruxism management. They provide customized treatment plans, including the use of splints and dental appliances, which directly target the condition. Patients are often more comfortable seeking treatment in these specialized settings, contributing to their larger market share. Conversely, hospitals and clinics are emerging players as they begin to recognize the importance of integrating dental care within their services. Their ability to offer a comprehensive approach, including medical evaluations and treatments, positions them for significant growth in the future as they adapt to the rising demand for holistic care.

Get more detailed insights about US Sleeping Bruxism Treatment Market

Key Players and Competitive Insights

The sleeping bruxism-treatment market is characterized by a competitive landscape that is increasingly shaped by innovation and strategic partnerships. Key players such as Procter & Gamble (US), Johnson & Johnson (US), and Colgate-Palmolive (US) are actively pursuing strategies that emphasize product development and market expansion. Procter & Gamble (US) has focused on enhancing its product portfolio through research and development, aiming to introduce advanced oral care solutions that address bruxism effectively. Meanwhile, Johnson & Johnson (US) appears to be leveraging its extensive distribution network to penetrate new markets, thereby increasing its market share. Colgate-Palmolive (US) is also investing in digital transformation initiatives, which may enhance customer engagement and streamline operations, collectively shaping a competitive environment that prioritizes innovation and customer-centric solutions.

In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure is moderately fragmented, with several players vying for dominance. This fragmentation allows for a diverse range of products and solutions, but it also intensifies competition among key players, who must continuously innovate to maintain their market positions.

In October 2025, Procter & Gamble (US) announced a partnership with a leading dental technology firm to develop a smart mouthguard that monitors bruxism activity. This strategic move is significant as it not only positions Procter & Gamble (US) at the forefront of technological innovation but also addresses the growing consumer demand for personalized health solutions. The integration of technology into traditional oral care products could redefine consumer expectations and enhance brand loyalty.

In September 2025, Johnson & Johnson (US) launched a new line of bruxism-related oral care products that incorporate natural ingredients aimed at reducing stress and anxiety, which are often linked to bruxism. This initiative reflects a broader trend towards holistic health solutions and may attract health-conscious consumers seeking alternative treatments. By diversifying its product offerings, Johnson & Johnson (US) is likely to strengthen its competitive position in the market.

In August 2025, Colgate-Palmolive (US) unveiled a digital platform that provides consumers with personalized recommendations for bruxism treatment based on their specific needs. This platform not only enhances customer engagement but also positions Colgate-Palmolive (US) as a leader in digital health solutions. The strategic importance of this move lies in its potential to create a more tailored consumer experience, thereby fostering brand loyalty and increasing market penetration.

As of November 2025, current trends in the sleeping bruxism-treatment market include a strong emphasis on digitalization, sustainability, and the integration of artificial intelligence (AI) into product development. Strategic alliances among companies are increasingly shaping the competitive landscape, allowing for shared resources and expertise. Looking ahead, it is anticipated that competitive differentiation will evolve, with a shift from price-based competition to a focus on innovation, technology, and supply chain reliability. This evolution may redefine market dynamics, compelling companies to prioritize unique value propositions that resonate with consumers.

Key Companies in the US Sleeping Bruxism Treatment Market market include

Industry Developments

Recent developments in the US Sleeping Bruxism Treatment Market have shown a significant focus on enhancing treatment options and the growing awareness of the condition. Sleep Number Corporation, known for its innovative sleep products, is exploring ways to integrate technology into bruxism management. GlaxoSmithKline and Eli Lilly and Company continue to invest in Research and Development for pharmacological treatments.

CPAP.com has reported increased sales of various oral appliances aimed at treating bruxism, reflecting the growing demand for effective solutions. Notably, Procter and Gamble's collaborations with dental care professionals emphasize the importance of preventive measures. Moreover, in March 2023, ResMed announced a strategic partnership with Johnson and Johnson to co-develop a new line of sleep disorder treatments, including those targeting bruxism.

Haleon and OralB have also been active in exploring consumer education campaigns to raise awareness. In the past two years, the US market has experienced a measurable increase in revenues, with growth projected due to rising awareness and improved treatment options. These changes reflect an evolving landscape aimed at addressing the needs of patients suffering from this common sleep-related condition.

Future Outlook

US Sleeping Bruxism Treatment Market Future Outlook

The Sleeping Bruxism Treatment Market is projected to grow at a 6.48% CAGR from 2024 to 2035, driven by increasing awareness and innovative treatment options.

New opportunities lie in:

  • Development of customized oral appliances for enhanced comfort and effectiveness.
  • Expansion of telehealth services for remote bruxism consultations.
  • Investment in AI-driven diagnostic tools for early detection and personalized treatment.

By 2035, the market is expected to achieve substantial growth, driven by innovation and increased consumer demand.

Market Segmentation

US Sleeping Bruxism Treatment Market Type Outlook

  • Primary Bruxism
  • Secondary Bruxism

US Sleeping Bruxism Treatment Market Cause Outlook

  • Obstructive Sleep Apnea
  • Gastroesophageal Reflux Disease (GERD)
  • Malocclusion
  • Sleep Paralysis

US Sleeping Bruxism Treatment Market End User Outlook

  • Hospitals & Clinics
  • Dental Clinics

US Sleeping Bruxism Treatment Market Treatment Outlook

  • Dental Approaches
  • Mouth Guard
  • NTI-TSS Device
  • Medication
  • Muscle Relaxants
  • Botulinum toxin type A Injections
  • Anti-anxiety Drugs

US Sleeping Bruxism Treatment Market Patient Type Outlook

  • Pediatric
  • Adult
  • Male
  • Female

Report Scope

MARKET SIZE 2024129.5(USD Million)
MARKET SIZE 2025137.89(USD Million)
MARKET SIZE 2035258.39(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)6.48% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Million
Key Companies Profiled["Procter & Gamble (US)", "GlaxoSmithKline (GB)", "Johnson & Johnson (US)", "Colgate-Palmolive (US)", "Dentsply Sirona (US)", "3M (US)", "Kavo Kerr (US)", "Oral-B (US)"]
Segments CoveredType, Cause, Treatment, Patient Type, End User
Key Market OpportunitiesIntegration of innovative oral devices and digital health solutions enhances treatment options in the sleeping bruxism-treatment market.
Key Market DynamicsRising consumer awareness drives demand for innovative treatments in the sleeping bruxism-treatment market.
Countries CoveredUS

Leave a Comment

FAQs

What is the expected market size of the US Sleeping Bruxism Treatment Market in 2024?

The US Sleeping Bruxism Treatment Market is expected to be valued at 138.65 million USD in 2024.

What is the projected market size for the US Sleeping Bruxism Treatment Market by 2035?

By 2035, the market is projected to reach a value of 257.62 million USD.

What is the expected CAGR for the US Sleeping Bruxism Treatment Market from 2025 to 2035?

The market is expected to grow at a CAGR of 5.794% from 2025 to 2035.

Which segment of the market holds more value in 2024, Primary or Secondary Bruxism?

In 2024, Primary Bruxism is valued at 83.36 million USD, while Secondary Bruxism is valued at 55.29 million USD.

How much is the Primary Bruxism segment expected to be worth in 2035?

The Primary Bruxism segment is expected to be valued at 156.52 million USD in 2035.

What is the expected value of the Secondary Bruxism segment by 2035?

By 2035, the Secondary Bruxism segment is anticipated to reach a value of 101.1 million USD.

Who are the key players in the US Sleeping Bruxism Treatment Market?

Major players in the market include Sleep Number Corporation, GlaxoSmithKline, Procter and Gamble, and Pfizer, among others.

What are the emerging trends in the US Sleeping Bruxism Treatment Market?

Emerging trends include increased awareness of dental health, technological advancements in treatment options, and rising demand for personalized care.

What challenges does the US Sleeping Bruxism Treatment Market currently face?

Challenges include lack of awareness, varying treatment effectiveness, and competition among numerous healthcare providers.

How is the current global scenario impacting the US Sleeping Bruxism Treatment Market?

The global scenario is influencing supply chains and treatment availability, but the demand for effective bruxism treatments remains strong.

What will be the projected market value of the US Sleeping Bruxism Treatment Market by 2035?

By 2035, the market is projected to reach 286.0 million USD.

What is the expected compound annual growth rate (CAGR) for the US Sleeping Bruxism Treatment Market from 2025 to 2035?

The market is expected to grow at a CAGR of 6.955% from 2025 to 2035.

Which type of bruxism holds a larger market share in 2024?

Primary Bruxism holds a larger market share valued at 80.0 million USD in 2024.

What is the projected market size for Secondary Bruxism by 2035?

The market size for Secondary Bruxism is projected to be 116.0 million USD by 2035.

What market opportunities exist in the US Sleeping Bruxism Treatment Market?

Emerging trends in dental technology and increasing awareness provide growth opportunities in the market.

What challenges does the US Sleeping Bruxism Treatment Market face?

The market faces challenges such as varying diagnosis rates and treatment adherence among patients.

What is the trend regarding market growth rate for Primary Bruxism from 2024 to 2035?

The market for Primary Bruxism is expected to grow significantly, from 80.0 million USD in 2024 to 170.0 million USD by 2035.

How does the current global scenario impact the US Sleeping Bruxism Treatment Market?

The ongoing global scenario influences supply chain stability in the US Sleeping Bruxism Treatment Market.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions